Nunzia Pharmaceutical Company
NUNZOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$43451
P/E Ratio—
52W High$0.003
52W Low$0.0001
Nunzia Pharmaceutical Company (NUNZ) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · NUNZ · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2021-12 | 2020-12 | 2019-12 | 2018-12 | 2017-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Margin %(computed) | — | — | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.08B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $0.08B | $0.00B | $0.00B | $0.00B | $0.00B |
| Operating Income | ($0.08B) | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.09B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.08B) | ($0.10B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.08B) | ($0.10B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.26 | $-0.35 | $-0.00 | $-0.00 | $-0.00 |
| Wtd Avg Shares | 0.31B | 0.28B | 0.25B | 0.15B | 0.15B |
| EBITDA | ($0.08B) | ($0.01B) | $0.00B | ($0.00B) | ($0.00B) |
| EBITDA Margin %(computed) | — | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · B
Explore more Nunzia Pharmaceutical Company data
About Nunzia Pharmaceutical Company (NUNZ) Income Statement
Nunzia Pharmaceutical Company (NUNZ) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2021, NUNZ reported revenue of $0.00B, gross profit of $0.00B (gross margin —), and net income of ($0.08B) — a net profit margin of —.
Frequently asked questions
NUNZ · 4 questionsNunzia Pharmaceutical Company (NUNZ) reported revenue of $0.00B for 2021, down —% year-over-year.
NUNZ revenueNUNZ salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09